Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)-Reference-Cited by-同舟云学术

Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)

Published:2003-10 Issue:2 Volume:123 Page:278-281
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Ru Xiuqing,Liebman Howard A.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04609.x/fullpdf

Reference25 articles.

1. Restoration of erythropoiesis by Rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment;Auner;British Journal of Haematology,2002

2. Repopulation of blood lymphocyte subpopulations in rheumatoid arthritis treated with the depleting monoclonal antibody, CAMPATH-1H;Brett;Immunology,1996

3. Pure red cell aplasia and lymphoma;Carloss;Journal of the American Medical Association,1979

4. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia;Casadevall;New England Journal of Medicine,1996

5. Pure red aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin;Casadevall;New England Journal of Medicine,2002

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent Large Granular Lymphocyte Clonal Expansions: “The Root of Many Evils”—And of Some Goodness;Cancers;2022-03-05

2. How I manage acquired pure red cell aplasia in adults;Blood;2021-04-15

3. Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids;Medicine;2019-10

Pathophysiologic Mechanisms And Management Of Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia

;OncoTargets and Therapy;2019-10

5. Bone Marrow Findings of Immune-Mediated Pure Red Cell Aplasia Following Anti-Programmed Cell Death Receptor-1 Therapy: A Report of Two Cases and Review of Literature;Journal of Hematology;2019